|
Volumn 18, Issue 2, 2003, Pages 96-102
|
Solid tumors in children
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBOPLATIN;
CARMUSTINE;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DACTINOMYCIN;
DOXORUBICIN;
ETOPOSIDE;
IFOSFAMIDE;
IRINOTECAN;
LOMUSTINE;
PACLITAXEL;
TOPOTECAN;
VINCRISTINE;
BRAIN TUMOR;
CANCER COMBINATION CHEMOTHERAPY;
CHILD;
CHILDHOOD CANCER;
CLINICAL FEATURE;
COMPUTER ASSISTED TOMOGRAPHY;
HUMAN;
NEPHROBLASTOMA;
NEUROBLASTOMA;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OSTEOSARCOMA;
REVIEW;
RHABDOMYOSARCOMA;
SOLID TUMOR;
ADOLESCENT;
CANCER STAGING;
FEMALE;
FOLLOW UP;
INFANT;
MALE;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
NEEDLE BIOPSY;
NURSING;
NURSING ASSESSMENT;
PATHOLOGY;
PRESCHOOL CHILD;
RISK ASSESSMENT;
SURVIVAL RATE;
ADOLESCENT;
BIOPSY, NEEDLE;
BRAIN NEOPLASMS;
CHILD;
CHILD, PRESCHOOL;
COMBINED MODALITY THERAPY;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INFANT;
MAGNETIC RESONANCE IMAGING;
MALE;
NEOPLASM STAGING;
NEUROBLASTOMA;
NURSING ASSESSMENT;
OSTEOSARCOMA;
RHABDOMYOSARCOMA;
RISK ASSESSMENT;
SURVIVAL RATE;
|
EID: 0037674011
PISSN: 08825963
EISSN: None
Source Type: Journal
DOI: 10.1053/jpdn.2003.12 Document Type: Article |
Times cited : (45)
|
References (7)
|